GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambee Pharmaceuticals Plc (DHA:AMBEEPHA) » Definitions » COGS-to-Revenue

Ambee Pharmaceuticals (DHA:AMBEEPHA) COGS-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2004. Start your Free Trial

What is Ambee Pharmaceuticals COGS-to-Revenue?

Ambee Pharmaceuticals's Cost of Goods Sold for the six months ended in . 20 was BDT0.00 Mil. Its Revenue for the six months ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals's COGS to Revenue for the six months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Ambee Pharmaceuticals's Gross Margin % for the six months ended in . 20 was N/A%.


Ambee Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Ambee Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambee Pharmaceuticals COGS-to-Revenue Chart

Ambee Pharmaceuticals Annual Data
Trend
COGS-to-Revenue

Ambee Pharmaceuticals Semi-Annual Data
COGS-to-Revenue

Ambee Pharmaceuticals COGS-to-Revenue Calculation

Ambee Pharmaceuticals's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

Ambee Pharmaceuticals's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambee Pharmaceuticals  (DHA:AMBEEPHA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Ambee Pharmaceuticals's Gross Margin % for the six months ended in . 20 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Ambee Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ambee Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ambee Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.

Ambee Pharmaceuticals Headlines

No Headlines